Lai Meiyao Industry: Net profit loss of 135 million yuan in 2025.

The announcement of Lai Mei Pharmaceuticals: The company's operating income in 2025 was 776 million yuan, a decrease of 2.50% year-on-year. The net loss attributable to shareholders of the listed company was 135 million yuan, compared to a net loss of 87.8044 million yuan in the same period last year. The company plans not to distribute cash dividends, bonus shares, or increase share capital through capital reserve.